Three Geojit Buy Calls Put Chart Signals in Focus
The analyst’s calls point to distinct technical setups—and different levels of confirmation and risk.
Geojit Investments’ Anand James has issued buy calls on Aarti Pharmalabs, Allied Blenders and Distillers, and Jeena Sikho Lifecare, citing chart breakouts and momentum indicators. The recommended targets and stop-loss levels vary, while Jeena Sikho’s setup still faces a near-term hurdle before its trend can strengthen.
Three charts, but not the same kind of signal
The recommendations are based on technical analysis rather than a comparison of company earnings, valuations or business prospects. James points to breakouts, moving-average positioning and momentum indicators as evidence supporting the calls. That distinction matters: chart strength can help identify trading setups, but it does not by itself establish that a company’s underlying business is improving.
The analyst’s stated targets are ₹1,080 for Aarti Pharmalabs, ₹810 for Allied Blenders and Distillers, and ₹455 for Jeena Sikho Lifecare. Each call also includes a stop-loss, giving investors a reference for managing downside if the technical view fails. These are analyst levels, not assured outcomes, and the stocks’ differing chart structures make it important to assess each setup on its own.
Aarti Pharmalabs: breakout follows consolidation
Aarti Pharmalabs had consolidated between ₹880 and ₹960 in late October and early November after rising from a ₹650-700 base in July and August. James says the stock then cleared a prior swing-high area around ₹960-975 on above-average volume. The move also completed what he describes as a weekly cup-and-handle pattern.
The stock is above its key moving averages, while the Supertrend indicator remains in buy mode and MACD is rising above its signal line. RSI at 68.72 indicates strong momentum, though it is nearing levels where some investors may become more cautious about chasing a move. The call sets a target of ₹1,080 and a stop-loss below ₹979, just under the breakout zone.
Allied Blenders presses against resistance
Allied Blenders and Distillers has been in an uptrend from its April low near ₹370, according to the analysis. After building a base between roughly ₹600 and ₹700 from June to October, it has formed higher lows and is testing the October swing-high zone around ₹760-770. The latest session’s above-average volume is cited as support for the move.
James sees a possible rounding-bottom breakout, with the stock above key moving averages and the Supertrend below the price. RSI stands at 66.91, while MACD has crossed above its signal line and the histogram has turned positive. The target is ₹810, with a stop-loss at ₹732, below the recent consolidation and breakout area. The resistance zone remains important: a failure to clear it could weaken the near-term setup.
Jeena Sikho’s recovery needs confirmation
Jeena Sikho Lifecare presents a less mature recovery signal. Following a prolonged decline from its May high near ₹780, the stock fell sharply at the end of September to the ₹310-320 zone. James says it has now closed above the upper trendline of a declining wedge and above its 10-day average for the first time since September.
Its RSI has turned up to 47.82 from deeply oversold levels, while the MACD histogram is showing what the analyst calls exhaustion candles. The initial hurdle is ₹385-400, where the Supertrend and pivot cluster converge. A decisive close above that band could strengthen momentum; the recommendation sets ₹455 as the target and ₹485 as an extended objective, with a stop-loss at ₹309 beneath the reversal base.
Key Highlights
- Aarti Pharmalabs: target ₹1,080; stop-loss below ₹979.
- Allied Blenders and Distillers: target ₹810; stop-loss at ₹732.
- Jeena Sikho Lifecare: target ₹455, with ₹485 as an extended objective; stop-loss at ₹309.
- Jeena Sikho faces an initial resistance zone at ₹385-400.
- The recommendations are technical calls and do not, on their own, assess fundamentals or valuation.
Investor Note: Treat these levels as the analyst’s trading framework, not a promise of returns. Investors should consider their own risk tolerance and whether they can act on the stated stop-loss levels; the technical signals may weaken if prices fail to hold their breakout or reversal zones.
Stay Ahead of the Market 📈
Subscribe to our weekly newsletter
Get your weekly market summary from FinBrooks Insights and smart financial lessons from FinBrooks Academy delivered straight to your inbox every weekend!